NCT02630927View on ClinicalTrials.gov

A Safety and Tolerability Study of AG-519 in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Anemia
Interventions
DRUG

AG-519

AG519 will be tested.

DRUG

Placebo

Placebo will be tested.

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington Fields

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY